亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies

内科学 医学 前瞻性队列研究 队列 肿瘤科 计算机科学
作者
Teerha Piratvisuth,Jinlin Hou,Tawesak Tanwandee,Thomas Berg,Arndt Vogel,Jörg Trojan,Enrico N. De Toni,Masatoshi Kudo,Anja Eiblmaier,Hanns‐Georg Klein,Johannes Kolja Hegel,Kairat Madin,Konstantin Kroeniger,Ashish Sharma,Henry Lik‐Yuen Chan
出处
期刊:Hepatology communications [Lippincott Williams & Wilkins]
卷期号:7 (11) 被引量:18
标识
DOI:10.1097/hc9.0000000000000317
摘要

Background: Alpha-fetoprotein (AFP) and des-gamma carboxyprothrombin (DCP), also known as protein induced by vitamin K absence-II (PIVKA-II [DCP]) are biomarkers for HCC with limited diagnostic value when used in isolation. The novel GAAD algorithm is an in vitro diagnostic combining PIVKA-II (DCP) and AFP measurements, age, and gender (biological sex) to generate a semi-quantitative result. We conducted prospective studies to develop, implement, and clinically validate the GAAD algorithm for differentiating HCC (early and all-stage) and benign chronic liver disease (CLD), across disease stages and etiologies. Methods: Patients aged ≥18 years with HCC or CLD were prospectively enrolled internationally into algorithm development [n = 1084; 309 HCC cases (40.7% early-stage) and 736 controls] and clinical validation studies [n = 877; 366 HCC cases (47.6% early-stage) and 303 controls]. Serum samples were analyzed on a cobas ® e 601 analyzer. Performance was assessed using receiver operating characteristic curve analyses to calculate AUC. Results: For algorithm development, AUC for differentiation between early-stage HCC and CLD was 90.7%, 84.4%, and 77.2% for GAAD, AFP, and PIVKA-II, respectively. The sensitivity of GAAD for the detection of early-stage HCC was 71.8% with 90.0% specificity. Similar results were shown in the clinical validation study; AUC for differentiation between early-stage HCC and CLD was 91.4% with 70.1% sensitivity and 93.7% specificity. GAAD also showed strong specificity, with a lower rate of false positives regardless of disease stage, etiology, or region. Conclusions: The GAAD algorithm significantly improves early-stage HCC detection for patients with CLD undergoing HCC surveillance. Further phase III and IV studies are warranted to assess the utility of incorporating the algorithm into clinical practice.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
重要静柏完成签到,获得积分10
10秒前
风中的芷珍完成签到,获得积分10
15秒前
哈哈完成签到,获得积分10
27秒前
健壮的安莲完成签到,获得积分10
40秒前
顾矜的应助被adgn采纳,获得10
42秒前
wwwww完成签到,获得积分10
43秒前
null的应助被科研通管家采纳,获得10
49秒前
null的应助被科研通管家采纳,获得10
49秒前
清脆夜阑完成签到,获得积分10
51秒前
fearless完成签到,获得积分10
53秒前
00hello00发布了新的文献求助10
1分钟前
彭于晏的应助被初景采纳,获得10
1分钟前
cliche完成签到,获得积分10
1分钟前
潇洒的大神完成签到,获得积分10
1分钟前
ZZWZHENG发布了新的文献求助10
1分钟前
jyy给jyy的求助进行了留言
1分钟前
哈哈完成签到 ,获得积分10
1分钟前
爱笑的芝麻完成签到,获得积分10
1分钟前
TXZ06发布了新的文献求助30
1分钟前
1分钟前
奔跑的应助被朱志伟采纳,获得10
1分钟前
nidie发布了新的文献求助10
1分钟前
英姑的应助被杰西咔采纳,获得10
1分钟前
1分钟前
初景发布了新的文献求助10
1分钟前
GingerF的应助被ZZWZHENG采纳,获得50
1分钟前
充电宝的应助被nidie采纳,获得10
1分钟前
柯青贤完成签到 ,获得积分10
1分钟前
ccc完成签到 ,获得积分10
1分钟前
1分钟前
号左左发布了新的文献求助10
2分钟前
2分钟前
柳贯一发布了新的文献求助10
2分钟前
畅快的夜云完成签到,获得积分10
2分钟前
xixiazhiwang完成签到 ,获得积分10
2分钟前
Maestro_S的应助被科研通管家采纳,获得10
2分钟前
null的应助被科研通管家采纳,获得10
2分钟前
2分钟前
要减肥青曼完成签到,获得积分10
2分钟前
庾傀斗发布了新的文献求助10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173025
求助须知:如何正确求助?哪些是违规求助? 9565519
关于积分的说明 21780282
捐赠科研通 7764983
什么是DOI,文献DOI怎么找? 3431516
关于科研通互助平台的介绍 2555600
邀请新用户注册赠送积分活动 2476658